Data / Form D filings / TUNDRA TARGETED THERAPEUTICS, INC.
TUNDRA TARGETED THERAPEUTICS, INC.: Form D filing
TUNDRA TARGETED THERAPEUTICS, INC., a biotechnology company in Madison, WI, filed a Form D with the SEC in 2025. The latest, on June 3, 2025, reports $443,500 sold of a $3 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 503 S PROSPECT AVE, Madison, WI, 53711
- Phone
- (608) 333-1505
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Wisconsin
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2070659
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2025 | New notice | $3,000,000 | $443,500 | $2,556,500 | 9 | Apr 30, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| JEDIAH WILDER WHITE | Executive Officer | |
| JEFFREY ARNOLD MEDIN | Executive Officer, Director | |
| JAMES ARNOLD CARAGHER | Executive Officer | |
| BRIAN ARNOLD OLSON | Executive Officer, Director |
Every Form D from the week of Jun 2, 2025 · All recent filings in Wisconsin · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what TUNDRA TARGETED THERAPEUTICS, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.